exp:news_feed:department site="cellbio" category_id="186" parse="inward" year="" month="" count="5"

News & Articles

From left, former student Xiao-Ming Xu, Ph.D., Mary Bartlett Bunge, Ph.D., and W. Dalton Dietrich, Ph.D.

Dr. Mary Bartlett Bunge, Who Made Major Contributions to The Miami Project, Retires

In 1989, Mary Bartlett Bunge, Ph.D., and her late husband, Richard P. Bunge, M.D., two of the world’s most respected researchers in the field of neurobiology, moved their laboratory from Washington University in St. Louis School of Medicine to the University of Miami Miller School of Medicine. The occasion for the move was Richard becoming the scientific director of The Miami Project to Cure Paralysis.

Read more »

DOD Funds Study of Link between Diabetes and Breast Cancer

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have received a three-year, $1.5 million grant to study a protein known as RAGE — an acronym for Receptor for Advanced Glycation End-products — that may be a link between diabetes and breast cancer.

Read more »

Medical campus update: Hurricane Irma

The latest on Hurricane Irma and how it is affecting the medical campus.

Read more »

Volunteer physicians and medical students in the Galapagos islands.

UM Medical Team Brings Life-Changing Eye Care to Remote Galapagos Island

It all started with a conversation between University of Miami Provost Thomas LeBlanc and Dr. Richard Lee of Bascom Palmer Eye Institute at a Faculty Senate event. The provost told Dr. Lee about an amazing experience he had had visiting a UM undergraduate program on Isabela Island in the Galapagos. He urged Lee to visit the island during a planned trip to Guayaquil to speak at an educational meeting.

Read more »

Clockwise from top left, Glen Barber, Ph.D., Ph.D. student Dillon Betancourt, Jeonghyun Ahn, Ph.D., Ph.D. student Nina de Queiroz, and Tianli Xia, Ph.D.

Miller School Researchers Move Forward with Development of Zika Vaccine

Following early-stage development of a vaccine to protect against the Zika virus, a group of researchers at the University of Miami Miller School of Medicine has published its initial findings. Now, with new funding, they are moving forward with non-human primate testing and, eventually, phase I human trials.

Read more »